These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33769715)

  • 1. Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatment.
    Brulhart-Meynet MC; Thomas A; Sidibé J; Visentin F; Dusaulcy R; Schwitzgebel V; Pataky Z; Philippe J; Vuilleumier N; James RW; Gosmain Y; Frias MA
    Physiol Rep; 2021 Mar; 9(6):e14786. PubMed ID: 33769715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.
    Cantrell Stanford J; Morris AJ; Sunkara M; Popa GJ; Larson KL; Özcan S
    J Biol Chem; 2012 Apr; 287(16):13457-64. PubMed ID: 22389505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate.
    Kurano M; Hara M; Tsuneyama K; Sakoda H; Shimizu T; Tsukamoto K; Ikeda H; Yatomi Y
    Biochim Biophys Acta; 2014 Sep; 1841(9):1217-26. PubMed ID: 24814049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate counteracts insulin signaling in pancreatic β-cells via the sphingosine 1-phosphate receptor subtype 2.
    Japtok L; Schmitz EI; Fayyaz S; Krämer S; Hsu LJ; Kleuser B
    FASEB J; 2015 Aug; 29(8):3357-69. PubMed ID: 25911610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
    Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
    J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
    Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
    Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells.
    Rütti S; Ehses JA; Sibler RA; Prazak R; Rohrer L; Georgopoulos S; Meier DT; Niclauss N; Berney T; Donath MY; von Eckardstein A
    Endocrinology; 2009 Oct; 150(10):4521-30. PubMed ID: 19628574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.
    Tong X; Peng H; Liu D; Ji L; Niu C; Ren J; Pan B; Hu J; Zheng L; Huang Y
    Cardiovasc Diabetol; 2013 Jan; 12():27. PubMed ID: 23360427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
    Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.
    Tong X; Lv P; Mathew AV; Liu D; Niu C; Wang Y; Ji L; Li J; Fu Z; Pan B; Pennathur S; Zheng L; Huang Y
    Cardiovasc Diabetol; 2014 Apr; 13():82. PubMed ID: 24751283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.
    Brinck JW; Thomas A; Lauer E; Jornayvaz FR; Brulhart-Meynet MC; Prost JC; Pataky Z; Löfgren P; Hoffstedt J; Eriksson M; Pramfalk C; Morel S; Kwak BR; van Eck M; James RW; Frias MA
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):817-24. PubMed ID: 26966278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype.
    Fayyaz S; Henkel J; Japtok L; Krämer S; Damm G; Seehofer D; Püschel GP; Kleuser B
    Diabetologia; 2014 Feb; 57(2):373-82. PubMed ID: 24292566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
    Ruiz M; Okada H; Dahlbäck B
    Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.
    Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F
    Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.
    Tatematsu S; Francis SA; Natarajan P; Rader DJ; Saghatelian A; Brown JD; Michel T; Plutzky J
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1788-94. PubMed ID: 23723371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate.
    Sato K; Malchinkhuu E; Horiuchi Y; Mogi C; Tomura H; Tosaka M; Yoshimoto Y; Kuwabara A; Okajima F
    Biochem Biophys Res Commun; 2007 Aug; 359(3):649-54. PubMed ID: 17544365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway.
    Izquierdo MC; Shanmugarajah N; Lee SX; Kraakman MJ; Westerterp M; Kitamoto T; Harris M; Cook JR; Gusarova GA; Zhong K; Marbuary E; O-Sullivan I; Rasmus N; Camastra S; Unterman TG; Ferrannini E; Hurwitz BE; Haeusler RA
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35104242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases.
    Diarte-Añazco EMG; Méndez-Lara KA; Pérez A; Alonso N; Blanco-Vaca F; Julve J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.